Athena Capital (South Africa) logo

Athena Capital (South Africa)

Africa, NA - South Africa, South Africa, Cape Town

Description

Athena Capital is an established private equity firm specializing in investments in middle market acquisitions.

Investor Profile

Athena Capital (South Africa) has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biopharma, Biotechnology, Life Science.

Stage Focus

  • Series B (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Athena Capital (South Africa) frequently co-invest with?

BVCF
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Platinum Asset Management
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Jebsen Capital
Asia, Hong Kong Island, Hong Kong, Causeway Bay
Co-Investments: 1
MF
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Athena Capital (South Africa)?

BioNTech

Mainz, Rheinland-Pfalz, Germany

BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series BJul 9, 2019
Amount Raised: $325,000,000